申请人:VYOME THERAPEUTICS LIMITED
公开号:US11045479B2
公开(公告)日:2021-06-29
The present disclosure relates generally to novel molecules, compositions, and formulations for treatment of bacterial infections in general and more specifically to bacterial infections with antibiotic resistant pathogens.
本公开内容一般涉及用于治疗细菌感染的新型分子、组合物和制剂,更具体地说,涉及具有抗生素耐药性病原体的细菌感染。